Prevalence and risk factors of diabetic retinopathy in subjects with suboptimal glycemic, blood pressure and lipid control. sankara nethralaya diabetic retinopathy epidemiology and molecular genetic study (SN-DREAMS, Report 33)

Current Eye Research

Volumn 37, Issue 6, 2012, Pages 513-523

  Raman, Rajiv ^a   Gupta, Aditi ^a   Kulothungan, Vaitheeswaran ^b   Sharma, Tarun ^a  

^a SANKARA NETHRALAYA   (India)

^b Department of Preventive Ophthalmology ^*  (India)

Author keywords

Diabetic retinopathy; Glycosylated hemoglobin; Hyperlipidemia; Hypertension; Suboptimal metabolic control

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANEMIA; ARTICLE; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIA; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SUBOPTIMAL CONTROL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INDIA; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84861066933     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.669005     Document Type: Article

References (52)

1. Morgan CL, Currie CJ, Stott NC, Smithers M, Butler CC, Peters JR. The prevalence of multiple diabetes-related complications. Diabet Med. 2000;17:146-151.
2. Long AN, Dagogo-Jack S. Comorbidities of diabetes and hypertension: Mechanisms and approach to target organ protection. J Clin Hypertens (Greenwich). 2011;13:244-251.
3. Howard BV, Magee MF. Diabetes and cardiovascular disease. Curr Atheroscler Rep. 2000;2:476-481.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
5. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
6. Pyorälä K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 1997;20:614-620.
7. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2002;25 Suppl 1:S33-S49.
8. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care. 2003;26 Suppl 1:S83-S86.
9. Coon P, Zulkowski K. Adherence to American Diabetes Association standards of care by rural health care providers. Diabetes Care. 2002;25:2224-2229.
10. Huang OS, Lamoureux EL, Tay WT, Tai ES, Wang JJ, Wong TY. Glycemic and blood pressure control in an Asian malay population with diabetes and diabetic retinopathy. Arch Ophthalmol. 2010;128:1185-1190.
11. Elis A, Rosenmann L, Chodick G, Heymann AD, Kokia E, Shalev V. The association between glycemic, lipids and blood pressure control among Israeli diabetic patients. QJM. 2008;101:275-280.
12. McFarlane SI, Castro J, Kaur J et al. Control of blood pressure and other cardiovascular risk factors at different practice settings: Outcomes of care provided to diabetic women compared to men. J Clin Hypertens (Greenwich). 2005;7:73-80.
13. Agarwal S, Raman R, Paul PG et al. Sankara Nethralaya- Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): Study design and research methodology. Ophthalmic Epidemiol. 2005;12:143-153.
14. Touitou Y, Portaluppi F, Smolensky MH, Rensing L. Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol Int. 2004;21:161-170.
15. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM; American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care. 2003;26 Suppl 1:S106-S108.
16. Anandaraja S, Narang R, Godeswar R, Laksmy R, Talwar KK. Low-density lipoprotein cholesterol estimation by a new formula in Indian population. Int J Cardiol. 2005;102:117-120.
17. Molitch ME, DeFronzo RA, Franz MJ et al.; American Diabetes Association. Nephropathy in diabetes. Diabetes Care. 2004;27 Suppl 1:S79-S83.
18. Raman R, Rani PK, Gnanamoorthy P, Sudhir RR, Kumaramanikavel G, Sharma T. Association of obesity with diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS Report no. 8). Acta Diabetol. 2010;47:209-215.
19. Deepa M, Farooq S, Deepa R, Manjula D, Mohan V. Prevalence and significance of generalized and central body obesity in an urban Asian Indian population in Chennai, India (CURES: 47). Eur J Clin Nutr. 2009;63:259-267.
20. Wang J, Russell-Aulet M, Mazariegos M et al. Body fat by dual photon absorptiometry (DPA): Comparisons with traditional methods in Asians,Blacks and Caucasians. Am J Hum Biol. 1992;4:501-510.
21. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84:137-144.
22. Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab. 2001;86:5366-5371.
23. Bild DE, Bluemke DA, Burke GL et al. Multi-ethnic study of atherosclerosis: Objectives and design. Am J Epidemiol. 2002;156:871-881.
24. Wong TT, Wong TY, Foster PJ, Crowston JG, Fong CW, Aung T; SiMES Study Group. The relationship of intraocular pressure with age, systolic blood pressure, and central corneal thickness in an Asian population. Invest Ophthalmol Vis Sci. 2009;50:4097-4102.
25. Buse JB, Ginsberg HN, Bakris GL et al.; American Heart AssociationAmerican Diabetes Association; . Primary prevention of cardiovascular diseases in people with diabetes mellitus: A scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007;115:114-126.
26. Klein R, Klein BE, Magli YL et al. An alternative method of grading diabetic retinopathy. Ophthalmology. 1986;93:1183-1187.
27. Menon VU, Guruprasad U, Sundaram KR, Jayakumar RV, Nair V, Kumar H. Glycaemic status and prevalence of comorbid conditions among people with diabetes in Kerala. Natl Med J India. 2008;21:112-115.
28. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.
29. Franklin SS. Hypertension in older people: Part 1. J Clin Hypertens (Greenwich). 2006;8:444-449.
30. Thijs L, Den Hond E, Nawrot T, Staessen JA. Prevalence, pathophysiology and treatment of isolated systolic hypertension in the elderly. Expert Rev Cardiovasc Ther. 2004;2:761-769.
31. Mancia G, Seravalle G, Grassi G. Systolic blood pressure: An underestimated cardiovascular risk factor. J Hypertens s. 2002;20:S21-S27.
32. Adler AI, Stratton IM, Neil HA et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study. BMJ. 2000;321:412-419.
33. Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T. Risk factors for diabetic retinopathy in selfreported rural population with diabetes. J Postgrad Med. 2009;55:92-96.
34. Varma R, Macias GL, Torres M, Klein R, Peña FY, Azen SP; Los Angeles Latino Eye Study Group. Biologic risk factors associated with diabetic retinopathy: The Los Angeles Latino Eye Study. Ophthalmology. 2007;114: 1332-1340.
35. Aguilar D, Hallman DM, Piller LB et al. Adverse association between diabetic retinopathy and cardiac structure and function. Am Heart J. 2009;157:563-568.
36. Janka HU, Ziegler AG, Valsania P, Warram JH, Krolewski AS. Impact of blood pressure on diabetic retinopathy. Diabete Metab. 1989;15:333-337.
37. Ishihara M, Yukimura Y, Aizawa T, Yamada T, Ohto K, Yoshizawa K. High blood pressure as risk factor in diabetic retinopathy development in NIDDM patients. Diabetes Care. 1987;10:20-25.
38. Shakya K, Shrestha JK, Joshi SN. Association between diabetic retinopathy and serum lipoproteins level. Nepal J Ophthalmol. 2009;1:107-113.
39. Ergün UG, Oztüzün S, Seydaoglu G. Lipoprotein (A) levels in type 2 diabetic patients with diabetic retinopathy. Med J Malaysia. 2004;59:406-410.
40. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology. 1984;91: 1464-1474.
41. Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology. 1989;96:1501-1510.
42. Stratton IM, Kohner EM, Aldington SJ et al. UKPDS 50: Risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44:156-163.
43. Klein R, Klein BE. Blood pressure control and diabetic retinopathy. Br J Ophthalmol. 2002;86:365-367.
44. Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM; UK Prospective Diabetes Study Group. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol. 2004;122:1631-1640.
45. Tan CS, Gay EM, Ngo WK. Is age a risk factor for diabetic retinopathy? Br J Ophthalmol. 2010;94:1268.
46. Pradeepa R, Anitha B, Mohan V, Ganesan A, Rema M. Risk factors for diabetic retinopathy in a South Indian Type 2 diabetic population-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4. Diabet Med. 2008;25:536-542.
47. Ranil PK, Raman R, Rachepalli SR et al. Anemia and diabetic retinopathy in type 2 diabetes mellitus. J Assoc Physicians India. 2010;58:91-94.
48. Manaviat MR, Afkhami M, Shoja MR. Retinopathy and microalbuminuria in type II diabetic patients. BMC Ophthalmol. 2004;4:9.
49. Potluri R, Purmah Y, Dowlut M, Sewpaul N, Lavu D. Microvascular diabetic complications are more prevalent in India compared to Mauritius and the UK due to poorer diabetic control. Diabetes Res Clin Pract. 2009;86:e39-e40.
50. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
51. Beck RW. The burgeoning public health impact of diabetes: The role of the ophthalmologist. Arch Ophthalmol. 2011;129:225-229.
52. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ. 2000;321:405-412.